SECOND SIGHT MEDICAL PRODUCT (EYES) Stock Analyst Earnings Estimates
NASDAQ:EYES - Nasdaq - US81362J3086 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.964M 99.85% | 6.896M -13.41% | 3.379M -51.00% | 2.635M -100.00% | 2.073M | 2.814M | 6.93M 146.31% | 17.325M 150.00% | |
| EBITDA YoY % growth | -28.152M 14.11% | -34.19M -21.45% | -30.2M 11.67% | -30.874M 58.60% | -28.66M 29.11% | N/A | N/A | N/A | |
| EBIT YoY % growth | -28.609M 13.85% | -34.625M -21.03% | -30.597M 11.63% | -31.323M 58.60% | -29.133M 29.48% | N/A | N/A | N/A | |
| Operating Margin | -359.23% | -502.10% | -905.50% | -1,188.64% | -1,405.45% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A -113.04% | N/A 5.45% | -6.54 48.62% | -8.39 87.00% | -10.58 -1,144.81% | -1.21 88.53% | -1.37 -13.07% | -1.37 |
| Q4 / 22 | |
|---|---|
| EPS Q2Q % growth | -1.21 15.00% |
| Revenue Q2Q % growth | 2.814M |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2020 Q2Q % growth | -0.06 96.00% | -0.44 | 0.38 | 86.32% |
| Q3 2020 Q2Q % growth | -0.07 95.14% | -0.43 | 0.36 | 83.66% |
| Q2 2020 Q2Q % growth | -0.45 73.21% | -1.25 | 0.80 | 64.13% |
| Q1 2020 Q2Q % growth | -1.71 10.94% | -1.25 | -0.46 | -36.30% |
| Q4 2019 Q2Q % growth | -1.50 | -1.50 | 0.00 | -0.04% |
| Q3 2019 Q2Q % growth | -1.44 | -1.47 | 0.03 | 1.96% |
| Q2 2019 Q2Q % growth | -1.68 | -1.47 | -0.21 | -14.38% |
| Q1 2019 Q2Q % growth | -1.92 | -1.47 | -0.45 | -30.72% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2020 Q2Q % growth | -100.00% | 245.629K | -245.629K | -100.00% |
| Q3 2020 Q2Q % growth | -100.00% | 244.614K | -244.614K | -100.00% |
| Q2 2020 Q2Q % growth | -100.00% | 244.8K | -244.8K | -100.00% |
| Q1 2020 Q2Q % growth | -100.00% | 242.76K | -242.76K | -100.00% |
| Q4 2019 Q2Q % growth | 500K | 477.36K | 22.64K | 4.74% |
| Q3 2019 Q2Q % growth | 470K | 955.74K | -485.74K | -50.82% |
| Q2 2019 Q2Q % growth | 1.28M | 462.06K | 817.94K | 177.02% |
| Q1 2019 Q2Q % growth | 1.13M | 1.694M | -564.22K | -33.30% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |